Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5
June 01, 2022 at 18:34 PM EDT
The companies said last month that three doses of the shot were 80% effective at preventing symptomatic COVID-19 and generated a robust immune response in children ages 6 months to 5 years old.
